|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
11 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Bad debt expense | |||||
| Impairment of property and equipment | |||||
| Loss on disposal of property and equipment | |||||
| Amortization of debt discount and issuance costs | |||||
| Share-based compensation expense | |||||
| Change in fair value of SAFE Agreements | |||||
| Change in fair value of earn-out liabilities | |||||
| Change in fair value of warrant liabilities | |||||
| Change in fair value of contingent consideration liabilities | |||||
| Loss on issuance of securities | |||||
| Deferred income taxes | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Trade accounts receivable, net | |||||
| Contract assets | |||||
| Prepaid expenses | |||||
| Other assets, net | |||||
| Accounts payable and accrued expenses | |||||
| Accounts payable – affiliated companies | |||||
| Contract liabilities – current and long-term | |||||
| Other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of property and equipment | |||||
| Purchase of intangible assets | |||||
| Acquisition of businesses, net of cash acquired | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from Business Combination | |||||
| Proceeds from issuance of Series A Preferred Stock | |||||
| Proceeds from issuance of convertible notes, net of discount | |||||
| Purchase of capped call transactions | |||||
| Payment of debt issuance costs | |||||
| Proceeds from issuance of securities | |||||
| Member distributions | |||||
| Net costs of stock option exercises | |||||
| Transaction costs | |||||
| Warrants exercised | |||||
| Redemption of warrants | |||||
| Repurchase of Class A Common Stock | |||||
| Proceeds from borrowings | |||||
| Repayment of loans | |||||
| Stock option exercises | |||||
| Forward purchase agreement termination | |||||
| Distributions to noncontrolling interests | |||||
| SAFE Agreements | |||||
| Payment of withholding taxes from share-based awards | |||||
| Net cash provided by financing activities | |||||
| Net increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of the period | |||||
| Cash, cash equivalents and restricted cash at end of the period | |||||
| Less: restricted cash | |||||
| Cash and cash equivalents at end of the period | |||||
| Supplemental disclosure of cash flow information | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes, net of income tax refunds | |||||
| Accrued capital expenditures | |||||
| Class A Common Stock issued in acquisition, at fair value | |||||
| Contingent consideration assumed at acquisition, Class A Common Stock | |||||
| Noncash financing activities: | |||||
| Transaction costs | |||||
| SAFE Agreements | |||||
| Issuance of stock | |||||
| Commitment Shares | |||||
| Class C Common Stock | |||||
| Total issuance of stock | |||||
| Conversion of Series A preferred stock (Note 10) | |||||
| Preferred dividends | |||||
Loading...